Thank You for Joining Our Academic Community!

We’re thrilled to welcome you as a new member of our journal. Your support helps advance scholarly research and ensures access to cutting-edge psychiatry articles and insights.

Choose your interests

Depression (MDD)

Schizophrenia/Schizoaffective Disorders

Neurology

Psychiatry

Bipolar Disorder

Addiction

Suicide

Posttraumatic Stress Disorder

Our Recently Published Articles

PCC
Lingual Dystonia After Taking Giloy Ghanvati
Case Report

July 1, 2025

A man experienced unsustained lingual dystonia after consuming giloy ghanvati (Tinospora cordifolia), which is an ayurvedic herbal preparation, along with alcohol consumption in a dependent pattern.
, , , et al
JCP
Using GenAI to Train Mental Health Professionals in Suicide Risk Assessment
Original Research

June 30, 2025

This preliminary study suggests that AI-Based Simulators show promise for improving mental health professionals’ self-efficacy in suicide risk assessment.
, , , et al
PCC
Conflict Mediation by CBT
Original Research

June 26, 2025

This study tested the effectiveness of the want/can/must strategy to mediate conflicts, in which the psychotherapist, a specialist in cognitive-behavioral therapy, acts as a facilitator.
, ,
PCC
Readability of Bipolar Disorder Measures
Original Research

June 26, 2025

Readability of self-assessment measures should be at or below a sixth grade reading level to be suitable for the general population.
, , , et al
PCC
Onco-Psychopharmacology: Is Mirtazapine a Catholicon?
Letter to the Editor

June 24, 2025

The author discusses the role of mirtazapine in the treatment of depression in patients with cancer.
JCP
Differentiating Subtypes of MDD Using Serum Biomarkers
Original Research

June 23, 2025

Significant differences in biomarker profiles were observed across MDD subtypes: the melancholic subtype showed higher cortisol levels and lower serotonin levels, and the atypical subtype showed elevated levels of…
, , , et al
JCP
SSRI Discontinuation and AUD Relapse
Case Report

August 26, 2024

A man with AUD achieves sobriety on treatment with an SSRI and naltrexone, but then stops taking the SSRI to participate in a psilocybin “ceremony.” What factors contributed to…
, , , et al
JCP
Olanzapine and Mirtazapine for Cancer-Related Anorexia
Clinical and Practical Psychopharmacology

August 21, 2024

Dr Andrade discusses two RCTs that investigated the utility of olanzapine and mirtazapine in addressing appetite loss in cancer patients.
JCP
Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine
Commentary

August 21, 2024

Dr Rosenbaum comments on the challenge of evaluating trials of treatments whose effects are unmistakable, and how this dilemma may be addressed.

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe